R Burgos-Vargas
Overview
Explore the profile of R Burgos-Vargas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
3125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kiltz U, van der Heijde D, Boonen A, Bautista-Molano W, Burgos-Vargas R, Chiowchanwisawakit P, et al.
RMD Open
. 2016 Oct;
2(2):e000311.
PMID: 27752358
Introduction: The Assessments of SpondyloArthritis international society Health Index (ASAS HI) measures functioning and health in patients with spondyloarthritis (SpA) across 17 aspects of health and 9 environmental factors (EF)....
2.
Hugle B, Burgos-Vargas R, Inman R, OShea F, Laxer R, Stimec J, et al.
Clin Exp Rheumatol
. 2014 Jan;
32(3):424-31.
PMID: 24387974
Objectives: A significant proportion of patients with juvenile spondyloarthritis (JSpA) are refractory to treatment with established medications. The objective of this study was to assess long-term efficacy of treatment with...
3.
Xibille-Friedmann D, Bustos Rivera-Bahena C, Rojas-Serrano J, Burgos-Vargas R, Montiel-Hernandez J
Scand J Rheumatol
. 2012 Dec;
42(2):102-7.
PMID: 23244209
Background: Several studies have confirmed that galectin-1 (Gal-1) plays a role in controlling the immune response because of its pro-apoptotic effect. Although studies based on a rheumatoid arthritis (RA) mouse...
4.
Burgos-Vargas R, Braun J, Casasola-Vargas J, Sieper J
Reumatol Clin
. 2011 Jul;
1 Suppl 2:S24-41.
PMID: 21794287
No abstract available.
5.
Pelaez-Ballestas I, Burgos-Vargas R
Reumatol Clin
. 2011 Jul;
1(3):166-74.
PMID: 21794257
Qualitative research in a clinical environment is an alternative in the study of the complexity of rheumatic diseases and takes patients' perspectives and their cultural contexts, as well as the...
6.
Pelaez-Ballestasa I, Melendez-Mercado C, Hernandez-Garduno A, Viramontes-Madrid J, Burgos-Vargas R
Reumatol Clin
. 2011 Jul;
1(2):116-20.
PMID: 21794246
Objective: To determine the prevalence of and identify drug-drug interactions (DDI) between non-steroidal anti-inflammatory drugs (NSAID) and other drugs in a prescription database of patients with rheumatic iseases. Material And...
7.
Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, et al.
Ann Rheum Dis
. 2011 May;
70(6):896-904.
PMID: 21540199
This first update of the ASAS/EULAR recommendations on the management of ankylosing spondylitis (AS) is based on the original paper, a systematic review of existing recommendations and the literature since...
8.
Gutierrez-Suarez R, Burgos-Vargas R
Clin Exp Rheumatol
. 2010 Nov;
28(5 Suppl 61):S122-7.
PMID: 21044445
Methotrexate (MTX) is one of the most useful drugs for the treatment of various rheumatic diseases in children, mainly juvenile idiopathic arthritis (JIA), juvenile dermatomyositis (JDM), and localised scleroderma. MTX...
9.
Merrill J, Burgos-Vargas R, Westhovens R, Chalmers A, DCruz D, Wallace D, et al.
Arthritis Rheum
. 2010 Jun;
62(10):3077-87.
PMID: 20533545
Objective: To evaluate abatacept therapy in patients with non-life-threatening systemic lupus erythematosus (SLE) and polyarthritis, discoid lesions, or pleuritis and/or pericarditis. Methods: In a 12-month, multicenter, exploratory, phase IIb randomized,...
10.
Xibille-Friedmann D, Bustos-Bahena C, Hernandez-Gongora S, Burgos-Vargas R, Montiel-Hernandez J
Ann Rheum Dis
. 2010 Apr;
69(5):930-1.
PMID: 20413571
No abstract available.